FierceBiotech

While the result fell short of the…

news2026-04-28T02:49:00+00:00April 28th, 2026|FierceBiotech|

For Jake Becraft, Ph.D., the…

news2026-04-28T02:42:00+00:00April 28th, 2026|FierceBiotech|

After a disappointing phase 1…

news2026-04-27T17:47:00+00:00April 27th, 2026|FierceBiotech|

After launching in 2025 as a…

news2026-04-27T14:51:00+00:00April 27th, 2026|FierceBiotech|

Both Seaport and Hemab are hoping…

news2026-04-27T11:41:00+00:00April 27th, 2026|FierceBiotech|

Compass Therapeutics shed half its…

news2026-04-27T10:41:00+00:00April 27th, 2026|FierceBiotech|

Astellas Pharma has done some…

news2026-04-27T10:22:00+00:00April 27th, 2026|FierceBiotech|

Oruka Therapeutics’ long-acting…

news2026-04-27T09:36:00+00:00April 27th, 2026|FierceBiotech|

A phase 3 trial of Intellia…

news2026-04-27T09:04:00+00:00April 27th, 2026|FierceBiotech|

Eli Lilly’s run of near-weekly…

news2026-04-27T08:00:00+00:00April 27th, 2026|FierceBiotech|

Previous789Next